Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 10:14:1136667.
doi: 10.3389/fpsyg.2023.1136667. eCollection 2023.

Neuropsychological measures of post-COVID-19 cognitive status

Affiliations

Neuropsychological measures of post-COVID-19 cognitive status

Alessandra Lauria et al. Front Psychol. .

Abstract

Background: COVID-19 may result in persistent symptoms in the post-acute phase, including cognitive and neurological ones. The aim of this study is to investigate the cognitive and neurological features of patients with a confirmed diagnosis of COVID-19 evaluated in the post-acute phase through a direct neuropsychological evaluation.

Methods: Individuals recovering from COVID-19 were assessed in an out-patient practice with a complete neurological evaluation and neuropsychological tests (Mini-Mental State Examination; Rey Auditory Verbal Test, Multiple Feature Target Cancellation Test, Trial Making Test, Digit Span Forward and Backward, and Frontal Assessment Battery). Pre- and post-COVID-19 global and mental health status was assessed along with the history of the acute phase of infection. Post-COVID-19 cognitive status was modeled by combining persistent self-reported COVID-related cognitive symptoms and pathologic neuropsychological tests.

Results: A total of 406 individuals (average age 54.5 ± 15.1 years, 45.1% women) were assessed on average at 97.8 ± 48.0 days since symptom onset. Persistent self-reported neurological symptoms were found in the areas of sleep (32%), attention (31%), and memory (22%). The MMSE mean score was 28.6. In total, 84 subjects (20.7%) achieved pathologic neuropsychological test results. A high prevalence of failed tests was found in digit span backward (18.7%), trail making (26.6%), and frontal assessment battery (10.9%). Cognitive status was associated with a number of factors including cardiovascular disease history, persistent fatigue, female sex, age, anxiety, and mental health stress.

Conclusion: COVID-19 is capable of eliciting persistent measurable neurocognitive alterations particularly relevant in the areas of attention and working memory. These neurocognitive disorders have been associated with some potentially treatable factors and others that may stratify risk at an early stage.

Keywords: COVID-19; Foggy Brain; cognitive evaluation; long COVID; neuropsychological assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Post-COVID-19 cognitive status. This figure shows the relative frequencies of the post-COVID-19 cognitive status. Surface area is proportional to relative frequencies. APCCD, asymptomatic post-COVID cognitive disturbances (no persistent symptoms but pathologic NPS tests); SPCCS, subjective persistent COVID-related cognitive sequelae (persistent symptoms but normal NPS tests); PCCD, persistent COVID-related cognitive disturbances (persistent symptoms and pathologic NPS test).
Figure 2
Figure 2
Factors associated with post-COVID-19 cognitive status. Adjusted odds ratios and 95% confidence intervals for the association between clinically relevant factors and post-COVID-19 cognitive outcomes. Intact cognition was set as the reference point. Red color means statistically significant association. APCCD, asymptomatic post-COVID cognitive disturbances (no persistent symptoms but pathologic NPS tests); SPCCS, subjective persistent COVID-related cognitive sequelae (persistent symptoms but normal NPS tests); PCCD, persistent COVID-related cognitive disturbances (persistent symptoms and pathologic NPS test); Ham-A, Hamilton anxiety scale; Ham-D, Hamilton depression scale; K10, Kessler Psychological Distress scale; Severity, Seven-category Ordinal Scale.

References

    1. Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., et al. . (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120–128. 10.1056/NEJMoa2015432 - DOI - PMC - PubMed
    1. Amalakanti S., Arepalli K. V. R., Jillella J. P. (2021). Cognitive assessment in asymptomatic COVID-19 subjects. Virusdisease. 32, 146–179. 10.21467/preprints.231 - DOI - PMC - PubMed
    1. Appollonio I., Leone M., Isella V., Piamarta F., Consoli T., Villa M. L., et al. . (2005). The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol. Sci. 26, 108–116. 10.1007/s10072-005-0443-4 - DOI - PubMed
    1. Bowie C. R., Harvey P. D. (2006). Administration and interpretation of the Trail Making Test. Nat. Protoc. 1, 2277–2281. 10.1038/nprot.2006.390 - DOI - PubMed
    1. Buysse D. J., Reynolds C. F., Monk T. H., Berman S. R., Kupfer D. J. (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193–213. 10.1016/0165-1781(89)90047-4 - DOI - PubMed

LinkOut - more resources